Finasteride attenuates pathological gambling in patients with Parkinson disease

J Clin Psychopharmacol. 2012 Jun;32(3):424-5. doi: 10.1097/JCP.0b013e3182549c2a.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • 5-alpha Reductase Inhibitors / therapeutic use*
  • Aged
  • Antiparkinson Agents / adverse effects*
  • Antiparkinson Agents / therapeutic use
  • Benzothiazoles / adverse effects
  • Benzothiazoles / therapeutic use
  • Cabergoline
  • Carbidopa / therapeutic use
  • Catechols / therapeutic use
  • Drug Combinations
  • Drug Monitoring
  • Drug Therapy, Combination / adverse effects
  • Ergolines / adverse effects
  • Ergolines / therapeutic use
  • Finasteride / therapeutic use*
  • Gambling / chemically induced
  • Gambling / prevention & control*
  • Humans
  • Levodopa / therapeutic use
  • Male
  • Middle Aged
  • Nitriles / therapeutic use
  • Parkinson Disease / drug therapy*
  • Pramipexole
  • Treatment Outcome
  • Video Games

Substances

  • 5-alpha Reductase Inhibitors
  • Antiparkinson Agents
  • Benzothiazoles
  • Catechols
  • Drug Combinations
  • Ergolines
  • Nitriles
  • carbidopa, levodopa drug combination
  • Levodopa
  • entacapone
  • Finasteride
  • Pramipexole
  • Cabergoline
  • Carbidopa